arrow
S

Shilpi Chandra

La Jolla Institute for Immunology
H指数:12
被引数:521

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy

iPSC来源的CAR T细胞通过工程化改造克服多种实体瘤疗效障碍,实现对HER2的偏好性肿瘤靶向。

2025-06-040
PRE
Transcriptomes and metabolism define mouse and human MAIT cell populations
2023-11-2410
OA
Divergent metabolic programmes control two populations of MAIT cells that protect the lung

不同的代谢程序控制两个保护肺的MAIT细胞群

2023-05-258
OAAI
OFF-THE-SHELF IPSC-DERIVED CAR-T CELLS CONTAINING SEVEN FUNCTIONAL EDITS OVERCOME ANTIGEN HETEROGENEITY, IMPROVE TRAFFICKING, AND WITHSTAND IMMUNOSUPPRESSION ASSOCIATED WITH FAILED TUMOR TREATMENT
2022-11-070
OA
CD1d-restricted peripheral T cell lymphoma in mice and humans
2016-04-1123
OAAI